People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Other Technology, Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CyteSi, Inc. | — | Other Technology | Series A | $12.4M | $32.4M | 2022 |
| MET Biotechnology Inc. | — | Biotech | Seed | $2.0M | $12.3M | 2024 |
Tung-Yu Wu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tung-Yu Wu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Xi Chen | 1 | 4 |
| Wing Hung Wong | 1 | 2 |
| Peng Hu | 1 | 1 |
| Ting-Hsiang Wu | 1 | 1 |
| Pei-Yu Chiou | 1 | 1 |
| Michael A. Teitell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.